PW, W., PD, B., R, P., B, R., G, C., PL, B., . . . ED, E. (2022). Clinical Utility of Universal Germline Genetic Testing for Patients With Breast Cancer. JAMA network open, 5(9), e2232787. https://doi.org/10.1001/jamanetworkopen.2022.32787
Chicago Style (17th ed.) CitationPW, Whitworth, et al. "Clinical Utility of Universal Germline Genetic Testing for Patients With Breast Cancer." JAMA Network Open 5, no. 9 (2022): e2232787. https://doi.org/10.1001/jamanetworkopen.2022.32787.
MLA (9th ed.) CitationPW, Whitworth, et al. "Clinical Utility of Universal Germline Genetic Testing for Patients With Breast Cancer." JAMA Network Open, vol. 5, no. 9, 2022, p. e2232787, https://doi.org/10.1001/jamanetworkopen.2022.32787.
Warning: These citations may not always be 100% accurate.